This topic contains a solution. Click here to go to the answer

Author Question: A nurse enters a client's room to check on his intravenous infusion. An electronic infusion device ... (Read 95 times)

LaDunn

  • Hero Member
  • *****
  • Posts: 526
A nurse enters a client's room to check on his intravenous infusion. An electronic infusion device is not being used.
 
  When checking the solution container and rate, the nurse notes that that fluid is infusing at a rate slower than intended. When assessing the client, which finding would the nurse identify as most likely contributing to the slowed rate of infusion?
  A) The client is resting his arm with the IV on his head.
  B) The tubing is visible, running freely from the solution to the access site.
  C) The fluid, although running slow, is infusing.
  D) The client is using his non-IV hand to push the IV pole when ambulating.

Question 2

A nurse is inspecting the IV access site of a client receiving intravenous therapy. The nurse suspects that the IV has infiltrated based on which finding at the site? Select all that apply.
 
  A) Swelling
  B) Redness
  C) Pallor
  D) Warmth to touch
  E) Pain



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jaymee143

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

Ans: A
Feedback:
When the extremity is elevated, such as the client resting his arm on his head, the fluid will infuse more slowly. Kinked or obstructed tubing (not visible and running freely), a patent catheter (such that the fluid is infusing), and the height of the solution container (such as when the client gets up and walks in the hall pushing the IV pole with the hand containing the IV) are factors that would contribute to a slowed rate.

Answer to Question 2

Ans: A, C, E
Feedback:
Infiltration is manifested by pain and by swelling around the infusion site which usually becomes cool to the touch. The area is also pale in color. Warmth and redness suggest phlebitis.





 

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Cytomegalovirus affects nearly the same amount of newborns every year as Down syndrome.

Did you know?

IgA antibodies protect body surfaces exposed to outside foreign substances. IgG antibodies are found in all body fluids. IgM antibodies are the first type of antibody made in response to an infection. IgE antibody levels are often high in people with allergies. IgD antibodies are found in tissues lining the abdomen and chest.

Did you know?

Pregnant women usually experience a heightened sense of smell beginning late in the first trimester. Some experts call this the body's way of protecting a pregnant woman from foods that are unsafe for the fetus.

Did you know?

Certain chemicals, after ingestion, can be converted by the body into cyanide. Most of these chemicals have been removed from the market, but some old nail polish remover, solvents, and plastics manufacturing solutions can contain these substances.

For a complete list of videos, visit our video library